137 related articles for article (PubMed ID: 30683097)
1. Glucose 6-phosphate dehydrogenase 6-phosphogluconolactonase: characterization of the Plasmodium vivax enzyme and inhibitor studies.
Haeussler K; Berneburg I; Jortzik E; Hahn J; Rahbari M; Schulz N; Preuss J; Zapol'skii VA; Bode L; Pinkerton AB; Kaufmann DE; Rahlfs S; Becker K
Malar J; 2019 Jan; 18(1):22. PubMed ID: 30683097
[TBL] [Abstract][Full Text] [Related]
2. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
Malar J; 2015 May; 14():218. PubMed ID: 26017006
[TBL] [Abstract][Full Text] [Related]
3. Fused Enzyme Glucose-6-Phosphate Dehydrogenase::6-Phosphogluconolactonase (G6PD::6PGL) as a Potential Drug Target in
Morales-Luna L; Vázquez-Bautista M; Martínez-Rosas V; Rojas-Alarcón MA; Ortega-Cuellar D; González-Valdez A; Pérez de la Cruz V; Arreguin-Espinosa R; Rodríguez-Bustamante E; Rodríguez-Flores E; Hernández-Ochoa B; Gómez-Manzo S
Microorganisms; 2024 Jan; 12(1):. PubMed ID: 38257939
[TBL] [Abstract][Full Text] [Related]
4. The glucose-6-phosphate dehydrogenase Mahidol variant protects against uncomplicated Plasmodium vivax infection and reduces disease severity in a Kachin population from northeast Myanmar.
Yi H; Li H; Liang L; Wu Y; Zhang L; Qiu W; Jiang W; Yang F; Li Q; Yang Z; Wang C; Cui L; He Y
Infect Genet Evol; 2019 Nov; 75():103980. PubMed ID: 31351234
[TBL] [Abstract][Full Text] [Related]
5. First Insight into Drug Resistance Genetic Markers, Glucose-6-Phosphate Dehydrogenase and Phylogenetic Patterns of Misdiagnosed Plasmodium vivax Malaria in Far North Region, Cameroon.
Kojom Foko LP; Jakhan J; Tamang S; Hawadak J; Kouemo Motse FD; Singh V
Curr Microbiol; 2023 Nov; 81(1):9. PubMed ID: 37968386
[TBL] [Abstract][Full Text] [Related]
6. Relating mutant genotype to phenotype via quantitative behavior of the NADPH redox cycle in human erythrocytes.
Coelho PM; Salvador A; Savageau MA
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927393
[TBL] [Abstract][Full Text] [Related]
7. An optimised system for refolding of human glucose 6-phosphate dehydrogenase.
Wang XT; Engel PC
BMC Biotechnol; 2009 Mar; 9():19. PubMed ID: 19284595
[TBL] [Abstract][Full Text] [Related]
8. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression.
Wu Q; Ge XL; Geng ZK; Wu H; Yang JY; Cao SR; Yang AL
Heliyon; 2024 Feb; 10(3):e25144. PubMed ID: 38322888
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional characterization of 6-phosphogluconate dehydrogenase in
Karthika A; Hemavathy N; Amala M; Rajamanikandan S; Veerapandian M; Prabhu D; Vetrivel U; Jung Chen C; Jeyaraj Pandian C; Jeyakanthan J
J Biomol Struct Dyn; 2024; 42(4):2058-2074. PubMed ID: 37599457
[TBL] [Abstract][Full Text] [Related]
10. Glucose 6-phosphate dehydrogenase variants increase NADPH pools for yeast isoprenoid production.
Adusumilli SH; Alikkam Veetil A; Choudhury C; Chattopadhyaya B; Behera D; Bachhawat AK
FEBS Open Bio; 2024 Mar; 14(3):410-425. PubMed ID: 38124687
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of active shikimate dehydrogenase from Plasmodium falciparum.
Morales BGDV; Evaristo JAM; Oliveira GAR; Garay AFG; Diaz JJAR; Arruda A; Pereira SS; Zanchi FB
An Acad Bras Cienc; 2024; 96(suppl 1):e20230382. PubMed ID: 38422345
[TBL] [Abstract][Full Text] [Related]
12. Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli.
Aon JC; Caimi RJ; Taylor AH; Lu Q; Oluboyede F; Dally J; Kessler MD; Kerrigan JJ; Lewis TS; Wysocki LA; Patel PS
Appl Environ Microbiol; 2008 Feb; 74(4):950-8. PubMed ID: 18083862
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of the amino terminal end of active site loop of lactate deyhdrogenase from Plasmodium vivax.
Mutlu O; Balık DT
Balkan Med J; 2012 Dec; 29(4):364-9. PubMed ID: 25207035
[TBL] [Abstract][Full Text] [Related]
14. Characterization of
Choi JW; Ha SO; Kim YJ; Shin JS; Choi MJ; Yu SE; Han J; Park EJ; Park KS; Kang JH
Microorganisms; 2024 Apr; 12(5):. PubMed ID: 38792706
[TBL] [Abstract][Full Text] [Related]
15. The enzymes of the oxidative phase of the pentose phosphate pathway as targets of reactive species: consequences for NADPH production.
Fuentes-Lemus E; Reyes JS; Figueroa JD; Davies MJ; López-Alarcón C
Biochem Soc Trans; 2023 Dec; 51(6):2173-2187. PubMed ID: 37971161
[TBL] [Abstract][Full Text] [Related]
16. Competitive oxidation of key pentose phosphate pathway enzymes modulates the fate of intermediates and NAPDH production.
Reyes JS; Cortés-Ríos J; Fuentes-Lemus E; Rodriguez-Fernandez M; Davies MJ; López-Alarcón C
Free Radic Biol Med; 2024 Jun; ():. PubMed ID: 38848786
[TBL] [Abstract][Full Text] [Related]
17. Kinetic properties of glucose 6-phosphate dehydrogenase and inhibition effects of several metal ions on enzymatic activity in vitro and cells.
Sun L; Sun B; Zhang Y; Chen K
Sci Rep; 2024 Mar; 14(1):5806. PubMed ID: 38461203
[TBL] [Abstract][Full Text] [Related]
18. G6PDH as a key immunometabolic and redox trigger in arthropods.
Moraes B; Martins R; Lopes C; Martins R; Arcanjo A; Nascimento J; Konnai S; da Silva Vaz I; Logullo C
Front Physiol; 2023; 14():1287090. PubMed ID: 38046951
[TBL] [Abstract][Full Text] [Related]
19. In Silico Screening and Molecular Dynamics Simulation of Potential Anti-Malarial Agents from
Heikal MF; Putra WE; Sustiprijatno ; Rifa'i M; Hidayatullah A; Ningsih FN; Widiastuti D; Shuib AS; Zulfiani BF; Hanasepti AF
Trop Life Sci Res; 2023 Jun; 34(2):1-20. PubMed ID: 38144376
[TBL] [Abstract][Full Text] [Related]
20. Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition.
Ding H; Chen Z; Wu K; Huang SM; Wu WL; LeBoeuf SE; Pillai RG; Rabinowitz JD; Papagiannakopoulos T
Sci Adv; 2021 Nov; 7(47):eabk1023. PubMed ID: 34788087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
